Epilepsy isn't always easy to diagnose. Seizures often don't occur during routine brain-wave recordings (EEGs), leaving doctors without the direct observation they need to make a clear diagnosis.

Researchers at the Francis Crick Institute and University College London (UCL), funded by Cancer Research UK and the European Research Council (ERC), have identified a 14-protein signature in the blood…

Eight companies have been selected to participate in the American Heart Association Heart and Brain Health Accelerator, a specialty track within the 2026 MedTech Innovator (MTI) Accelerator.

When national tragedy strikes, the urge to light up isn't just a habit, it is a psychological defense mechanism.

The thresholds for kidney function currently used to diagnose chronic kidney disease (CKD) reflect a true increase in the risk of serious illness.

Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells to remain hidden for years before triggering a relapse, which…

Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer's disease pathology leads to…

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic tumors—something…

A new study to be presented at the SLEEP 2026 annual meeting found that irregular sleep - including variability in sleep timing and duration - was associated with lower receptive…

Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in mass photometry technology, today announced a first‑of‑its‑kind integrated workflow for the characterization…